Study S000349

The Efficacy and Safety of Adjuvant GLP-1 Receptor Agonist Therapy Following Metabolic Bariatric Surgery in Chinese Patients With Obesity: A Prospective, Monocentric, Stratified Randomized Controlled Trial

ClinicalTrials.gov record

Registration

Registration: NCT07633639
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Masking: NONE
Status: RECRUITING
Enrollment: 200
Start: 2026-05-01
Primary completion: 2028-05-01
Lead sponsor: China-Japan Friendship Hospital
Conditions: Obesity
Interventions: COMBINATION_PRODUCT:LSG-Semaglutide group; COMBINATION_PRODUCT:LSG-Mazdutide group; COMBINATION_PRODUCT:LSG-Tirzepatide group; PROCEDURE:LSG group
Results posted: FALSE

Registered primary outcomes

Percentage of weight loss. [Immediately postoperatively (Day 0), and at 1, 3, 6, and 12 months postoperatively.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.